15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering AtriCure Inc, 6 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $45.00 to $55.00, so the covering firms are broadly aligned. The average target of $51.50 sits 29% above the current $39.77. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 13% this year and 12% next, consensus EPS building from about $0.09 next quarter toward $0.45 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Moderate Buy
Strong Buy00%
Buy686%
Hold114%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to AtriCure Inc.
As of Jul, 6 of 7 firms rate ATRC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ATRC EPS & revenue forecast
EPS · NEXT QUARTER
$0.09
Range $0.06 – $0.13 · 6 analysts · +52% YoY
Next period, 6 analysts expect AtriCure Inc to earn $0.09 a share (range $0.06 – $0.13), versus $0.06 a year earlier. Full-year consensus is $0.26, growing to $0.45 the year after.
REVENUE · NEXT QUARTER
$160.2M
Range $158.4M – $162.4M · 6 analysts · +13% YoY
Revenue is expected to reach $160.2M (range $158.4M – $162.4M), +13.0% year-over-year. Full-year consensus is $606.1M, rising to $679.3M next year.
Top analysts covering AtriCure Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ATRC.
#1
William Plovanic
Canaccord Genuity · Rank #190
Buy
$55.00+38.3% to target
Overall win rate
36%
+ Follow
#2
Mike Matson
Needham · Rank #204
Buy
$45.00+13.2% to target
Overall win rate
31%
+ Follow
#3
Matt O'Brien
Piper Sandler · Rank #356
Buy
$50.00+25.7% to target
Overall win rate
25%
+ Follow
#4
DS
Daniel Stauder
JMP Securities
Buy
$52.00+30.8% to target
Coverage
—
+ Follow
#5
MT
Marie Thibault
BTIG
Buy
$45.00+13.2% to target
Coverage
—
+ Follow
ATRC stock forecast FAQ
What is ATRC's average 12-month price target?+
The 6 analysts with a live target average $51.50 for AtriCure Inc over the next 12 months, ranging from a $55.00 high to a $45.00 low.
Is ATRC stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 7 analyst ratings, 6 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ATRC?+
The Street-high target is $55.00 (Canaccord Genuity), and the Street-low is $45.00 (Needham). The average of all 6 active targets is $51.50.
How many Wall Street analysts cover ATRC?+
7 analysts have an active rating on AtriCure Inc, and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering ATRC?+
Among analysts who currently cover ATRC, William Plovanic of Canaccord Genuity has the strongest overall Quantellect track record (Rank #190). Their current call is Buy with a $55.00 target.
What is AtriCure Inc's projected EPS for next quarter?+
The consensus estimate is $0.09 per share (range $0.06 – $0.13) across 6 analysts. Full-year EPS is projected at $0.26, rising to $0.45 the following year.
How much revenue is AtriCure Inc expected to report next quarter?+
Consensus revenue is $160.2M (range $158.4M – $162.4M). Full-year revenue is projected at $606.1M, growing to $679.3M next year.
Have analysts been upgrading or downgrading ATRC lately?+
As of Jul, 6 of 7 firms rate ATRC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ATRC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
